Literature DB >> 8366288

T-cell surface molecule expression and interferon-gamma production in human cord blood.

A Kruse1, P Neustock, M Reuter, H Kirchner.   

Abstract

We investigated T-cell surface antigen expression and the production of interferon-gamma (IFN-gamma) and interleukin-2 (IL-2) by human cord and adult blood cells. Cord blood lymphocytes stimulated with Staphylococcus enterotoxin B (SEB) released only minimal titers of IFN-gamma and IL-2 in comparison with adult blood lymphocytes. Systematic analyses of several cell-surface molecules on untreated cord blood and adult blood T cells demonstrated a significant reduction of CD8+ subset numbers in cord blood. Furthermore, cord blood lymphocytes did not express the memory T-cell marker CD45RO. No differences were found in gamma/delta T-cell receptor (TCR), CD5, and CD25 antigen expression between untreated cord blood and adult blood. However, cord blood mononuclear cells showed a decreased CD25 antigen expression in comparison to those of adults following activation with SEB. These observations suggest that the decrease in the proportion of some T-cell subsets and the absence of CD45RO memory T cells may be responsible for the diminished lymphokine production of cord blood lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8366288     DOI: 10.1089/jir.1993.13.221

Source DB:  PubMed          Journal:  J Interferon Res        ISSN: 0197-8357


  2 in total

1.  Differential effects of human immunodeficiency virus type 1 envelope protein gp120 on interferon production by mononuclear cells from adults and neonates.

Authors:  M P Nair; K C Chadha; I Stadler; A Sweet; S A Schwartz
Journal:  Clin Diagn Lab Immunol       Date:  1995-07

2.  Age- and infection-related maturation of the nasal immune response in 0-2-year-old children.

Authors:  I J van Benten; C M van Drunen; L P Koopman; B C van Middelkoop; W C J Hop; A D M E Osterhaus; H J Neijens; W J Fokkens
Journal:  Allergy       Date:  2005-02       Impact factor: 13.146

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.